Form 8-K - Current report:
SEC Accession No. 0000950170-25-081607
Filing Date
2025-06-04
Accepted
2025-06-04 16:05:10
Documents
10
Period of Report
2025-06-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20250604.htm   iXBRL 8-K 46127
  Complete submission text file 0000950170-25-081607.txt   157249

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20250604.xsd EX-101.SCH 27184
13 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20250604_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 251023098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)